Industry News
Pharmaceutical Industry News
New Mexico health officials link misuse of ivermectin to two Covid-19 deaths.
Calls to poison control centers have soared across the country as misinformation spreads touting the anti-parasite drug as a Covid treatment.
Facing class action lawsuit over insulin pricing, Novo Nordisk inks $100M settlement with disgruntled investors
Facing class action lawsuit over insulin pricing, Novo Nordisk inks $100M settlement with disgruntled investors kdunleavy Fri, 09/24/2021 - 15:32
W.H.O. Backs Antibody Treatment For High-Risk Covid Patients
The expensive treatment, developed by the U.S. drug maker Regeneron and the Swiss biotech company Roche, has garnered attention as backstop for those who shun vaccines.
Gilead, Merck and others slapped with ‘pay-for-delay’ lawsuits over lucrative HIV and cholesterol meds
Gilead, Merck and others slapped with 'pay-for-delay' lawsuits over lucrative HIV and cholesterol meds nhigginsdunn Fri, 09/24/2021 - 11:39
FDA’s ongoing review of accelerated cancer approvals targets 2 drugs from Secura and Aurobindo
FDA's ongoing review of accelerated cancer approvals targets 2 drugs from Secura and Aurobindo aliu Fri, 09/24/2021 - 11:24
Responding to global vaccine demand, Cytiva pledges $52.5M to build South Korean factory
Responding to global vaccine demand, Cytiva pledges $52.5M to build South Korean factory jkeenan Fri, 09/24/2021 - 10:48
Regeneron and Roche’s COVID drug wins WHO backing, but agency calls for lower prices and better access
Regeneron and Roche's COVID drug wins WHO backing, but agency calls for lower prices and better access kdunleavy Fri, 09/24/2021 - 10:10
Merck will pay royalties on next-gen pneumococcal shot to settle Pfizer patent fight
Merck will pay royalties on next-gen pneumococcal shot to settle Pfizer patent fight esagonowsky Fri, 09/24/2021 - 09:44
AstraZeneca, Merck target broad use of Lynparza in prostate cancer as PARP rivals Pfizer, J&J, Clovis loom
AstraZeneca, Merck target broad use of Lynparza in prostate cancer as PARP rivals Pfizer, J&J, Clovis loom aliu Fri, 09/24/2021 - 09:34
Fierce Pharma Asia—Enhertu’s big win; Biogen-Samsung’s Lucentis biosimilar; Clover’s COVID vaccine data
Fierce Pharma Asia—Enhertu's big win; Biogen-Samsung's Lucentis biosimilar; Clover's COVID vaccine data aliu Fri, 09/24/2021 - 05:19
C.D.C. Panel Recommends Pfizer Boosters for Many Americans, but Not Health Workers
Scientific advisers to the C.D.C. also recommended the coronavirus vaccine boosters for those with certain medical conditions, but excluded those at risk because of their jobs.
CDMO Lonza strikes deal with Allarity Therapeutics to manufacture cancer drug candidate dovitinib
CDMO Lonza strikes deal with Allarity Therapeutics to manufacture cancer drug candidate dovitinib kdunleavy Thu, 09/23/2021 - 15:42
Takeda breached its contract with AbbVie by failing to supply prostate cancer drug Lupron, court rules
Takeda breached its contract with AbbVie by failing to supply prostate cancer drug Lupron, court rules kdunleavy Thu, 09/23/2021 - 11:27
Vaccine players in Argentina, Brazil selected as regional producers for COVID-19 shots
Vaccine players in Argentina, Brazil selected as regional producers for COVID-19 shots jkeenan Thu, 09/23/2021 - 09:55
Faced with generic rivals, Amarin cuts 400-plus sales reps as part of revamped Vascepa strategy
Faced with generic rivals, Amarin cuts 400-plus sales reps as part of revamped Vascepa strategy nhigginsdunn Thu, 09/23/2021 - 09:52
Amid heated debate, FDA hands limited nod to Pfizer for COVID-19 vaccine boosters
Amid heated debate, FDA hands limited nod to Pfizer for COVID-19 vaccine boosters kdunleavy Thu, 09/23/2021 - 09:40
On a JAK roll, Incyte wins FDA green light to expand Jakafi in chronic graft-versus-host disease
On a JAK roll, Incyte wins FDA green light to expand Jakafi in chronic graft-versus-host disease aliu Thu, 09/23/2021 - 09:14
Pfizer CEO Bourla asks employees to join the scrum for D.C. drug-pricing fight
Pfizer CEO Bourla asks employees to join the scrum for D.C. drug-pricing fight esagonowsky Thu, 09/23/2021 - 09:08
Takeda breaks ground on $14M green building at Singapore manufacturing plant
Takeda breaks ground on $14M green building at Singapore manufacturing plant jkeenan Thu, 09/23/2021 - 08:47
Do not enter: Biogen reps banned from D.C.-area neurology clinics over controversial Alzheimer’s drug Aduhelm
Do not enter: Biogen reps banned from D.C.-area neurology clinics over controversial Alzheimer's drug Aduhelm nhigginsdunn Wed, 09/22/2021 - 16:46